Forty-seven patients with unexplained chest pain and normal resting echocardiograms were examined to see whether dynamic mid-ventricular obstruction (MVO) is induced by dobutamine infusion. Dynamic MVO was provoked in 17 patients (MVO group), but not in the other 30 patients (Non-MVO group). Before dobutamine infusion, the blood pressure in the MVO group was higher than that in the Non-MVO group (p < 0.05), but end-diastolic volume index (p < 0.001), end-systolic volume index (p < 0.01), stroke volume index (p < 0.001), cardiac index (p < 0.001), end-diastolic volume (p < 0.01) and end-systolic volume (p < 0.05) of the apical territory of the left ventricle in the MVO group were significantly less than those in the Non-MVO group. The left atrial function, left ventricular ejection fraction and ejection fraction of the apical territory of the left ventricle did not differ between the groups. Seven patients in the MVO group were re-examined by dobutamine stress echocardiography after beta-blocker administration, showing that the dynamic MVO was completely suppressed. The end-diastolic volume tended to increase after beta-blocker administration, but no significant difference was found in any other variables except heart rate. The results suggest that a smaller left ventricle and higher blood pressure are important characteristics in patients with dobutamine-induced dynamic MVO, and additionally, the difference in local myocardial contractility may be an important cause of the induction of dynamic MVO.
Download full-text PDF |
Source |
---|
J Soc Cardiovasc Angiogr Interv
May 2024
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Background: Supersaturated oxygen (SSO) delivered into the left anterior descending coronary artery after percutaneous coronary intervention (PCI) for anterior ST-segment elevation myocardial infarction (STEMI) has been shown to reduce infarct size, but its effects on microvascular obstruction (MVO) are unknown. The aim of this study was to compare MVO in patients with anterior STEMI treated with SSO after successful primary PCI from 2 studies (the optimized SSO pilot and IC-HOT) with similar patients from 7 randomized trials who underwent primary PCI without SSO treatment.
Methods: A total of 874 patients with anterior STEMI who underwent MVO assessment using cardiac magnetic resonance imaging within 10 days after primary PCI were included, of whom 90 patients (10.
Cardiovasc Ultrasound
August 2024
Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
From its inception as a two-dimensional snapshot of the beating heart, echocardiography has become an indelible part of cardiovascular diagnostics. The integration of ultrasound enhancing agents (UEAs) marks a pivotal transition, enhancing its diagnostic acumen beyond myocardial perfusion. These agents have refined echocardiography's capacity to visualize complex cardiac anatomy and pathology with unprecedented clarity, especially in non-coronary artery disease contexts.
View Article and Find Full Text PDFAm Heart J
May 2024
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:
Background: Mortality after ST-segment elevation myocardial infarction (STEMI) is increased in patients with hypertension. The mechanisms underlying this association are uncertain. We sought to investigate whether patients with STEMI and prior hypertension have greater microvascular obstruction (MVO) and infarct size (IS) compared with those without hypertension.
View Article and Find Full Text PDFObesity (Silver Spring)
March 2024
Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus N, Denmark.
Objective: A ketogenic diet (KD) characterized by very low carbohydrate intake and high fat consumption may simultaneously induce weight loss and be cardioprotective. The "thrifty substrate hypothesis" posits that ketone bodies are more energy efficient compared with other cardiac oxidative substrates such as fatty acids. This work aimed to study whether a KD with presumed increased myocardial ketone body utilization reduces cardiac fatty acid uptake and oxidation, resulting in decreased myocardial oxygen consumption (MVO ).
View Article and Find Full Text PDFJ Clin Med
August 2023
Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse 36, 80636 Munich, Germany.
Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is highly dynamic, develops gradually (over hours) and persists for days to weeks after reperfusion. Microvascular obstruction (MVO) developing as a consequence of myocardial ischemia, distal embolization and reperfusion-related injury is the main pathophysiological mechanism of CNR.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!